Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Allarity Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 3 | +3 |
| Shares | 0 | 26.0K | +26.0K |
| Value | $0 | $270.0K | +$270.0K |
New holders (3)
Institutions that held Allarity Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ExodusPoint Capital Management, LP | 25,917 | $269.0K | 0.00% |
| UBS Group AG | 109 | $1.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 9 | $0 | 0.00% |
Sold out (0)
Institutions that held Allarity Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
None.